News
TRIB
1.370
+0.96%
0.013
Trinity biotech receives European approval for rapid COVID-19 antigen test
Trinity Biotech (NASDAQ:TRIB) said on Friday it had achieved the European CE Mark or approval for its 10-minute Covid-19 antigen test.  This CE mark allows for use by healthcare professionals and
Seekingalpha · 05/20 15:54
Trinity Biotech Announces CE Mark Of Its 10-Minute Covid-19 Antigen Test
Trinity Biotech plc (NASDAQ:TRIB) has achieved a CE Mark for its 10-minute Covid-19 antigen test. This CE mark allows for use by healthcare professionals and trained users. The Company intends to launch the test
Benzinga · 05/20 13:21
Trinity Biotech Announces CE Mark of its 10-Minute Covid-19 Antigen Test
DUBLIN, Ireland, May 20, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has achieved a CE Mark for its 10-minute Covid-19 antigen test. This CE mark allows for use by healthcare professionals and trained users. The Company intends to launch th...
GlobeNewswire · 05/20 13:20
Trinity Biotech Announces the Successful Closing of its Strategic Investment and Partnership With The MiCo Group of South Korea
DUBLIN, Ireland, May 03, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced that it has closed its recently announc...
GlobeNewswire · 05/03 22:50
Trinity Biotech reports Q4 results
Trinity Biotech press release (NASDAQ:TRIB): Q4 GAAP EPADS of -0.4 cents. Revenue of $19.53M (-40.4% Y/Y). Gross profit for Q4, 2021 amounted to $7.2M equating to a gross margin of
Seekingalpha · 04/12 04:29
BRIEF-Trinity Biotech Reports $45 Mln Strategic Investment And Partnership With The MiCo Group of South Korea
reuters.com · 04/11 14:56
BRIEF-Trinity Biotech Announces Q4 And Fiscal Year 2021 Financial Results
reuters.com · 04/11 13:25
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Hoth Therapeutics (NASDAQ:HOTH) stock rose 156.5% to $1.58 during Monday's pre-market session. The market value of their outstanding shares is at $37.8 million.
Benzinga · 04/11 13:22
Trinity Biotech jumps 13% after Korea's MiCo acquires stake at premium
Trinity Biotech (NASDAQ:TRIB) stated Monday that it has secured $45M equity plus debt investment in partnership deal with listed Korean biomedical company - MiCo.  The investment comprises of 11.2M Trinity ADS
Seekingalpha · 04/11 13:05
Trinity Biotech Announces Quarter 4 and Fiscal Year 2021 Financial Results
DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended Decembe...
GlobeNewswire · 04/11 13:00
Trinity Biotech Announces A $45M Strategic Investment And Partnership With The MiCo Group Of South Korea
Trinity Biotech plc (NASDAQ:TRIB), a leading global diagnostic company ("Trinity Biotech" or the "Company"), today announced a $45 million strategic investment and partnership with MiCo Ltd
Benzinga · 04/11 12:20
Trinity Biotech Receives $45 Million MiCo Investment, Forms Strategic Partnership; ADSs Climb
MT Newswires · 04/11 10:50
Stocks That Hit 52-Week Lows On Monday
  On Monday morning, 66 companies achieved new lows for the year.
Benzinga · 02/28 15:43
BRIEF-Trinity Biotech Announces The World Health Organisation Approval Of Trinscreen™ Hiv
reuters.com · 02/14 14:31
Trinity Biotech wins WHO approval for HIV screening test
Trinity Biotech (NASDAQ:TRIB) announced on Monday that the World Health Organisation (WHO) approved its new HIV screening product, TrinScreen HIV. In Africa, Trinity Biotech (TRIB) has led the market for
Seekingalpha · 02/14 13:48
Trinity Biotech shares jump 6% premarket after WHO approves is rapid test for HIV
Dublin-based Trinity Biotech Plc shares jumped 6% premarket Monday, after the company said it has received approval from the World Health Organization for its HIV screening product, TrinScreen. The company's Uni-Gold HIV product has served as the main conf...
marketwatch.com · 02/14 13:31
Trinity Biotech Announces World Health Organisation Approval Of TrinScreen HIV
Trinity Biotech plc (NASDAQ:TRIB) has received approval for its new HIV screening product, TrinScreen™ HIV, from the World Health Organisation (WHO).   TrinScreen™ HIV Trinity Biotech's
Benzinga · 02/14 13:12
Trinity Biotech Announces the World Health Organisation Approval Of TrinScreen™ HIV
DUBLIN, Ireland, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has received approval for its new HIV screening product, TrinScreen™ HIV, from the World Health Organisation (WHO). TrinScreen™ HIV Trinity Biotech’s Uni-Gold™ HIV produc...
GlobeNewswire · 02/14 13:10
Trinity Biotech Secures WHO Approval for HIV Test
MT Newswires · 02/14 09:24
BRIEF-Trinity Biotech PLC - John Gillard, Group CFO, Has Informed Board Of His Intention To Resign
reuters.com · 02/11 12:36
More
Webull provides a variety of real-time TRIB stock news. You can receive the latest news about Trinity Biotech Plc through multiple platforms. This information may help you make smarter investment decisions.
About TRIB
Trinity Biotech Public Limited Company through its subsidiaries develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC)segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. It operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business.